For other plasma biomarkers, the current study’s results showed that plasma p-tau181 and plasma NFL had fair performance in identifying amyloid-positive participants with cognitive impairments (AUC 0.67 and 0.62, respectively). The gene discussed is NEFL; the disease is Cognitive impairment.